Header Logo

Connection

Robert Wild to Humans

Back to Details
This is a "connection" page, showing publications Robert Wild has written about Humans.
Robert Wild
Connection Strength
1.898
Humans
  1. Short cycles: more menopause symptoms during transition. Menopause. 2022 10 01; 29(10):1121-1122.
    View in: PubMed
    Score: 0.047
  2. Proprotein Convertase Subtilisin Kexin 9 (PCSK9) and nonHDL particles rise during normal pregnancy and differ by BMI. J Clin Lipidol. 2022 Jul-Aug; 16(4):483-490.
    View in: PubMed
    Score: 0.046
  3. A Possible Screening Marker for Cardiovascular Disease in Polycystic Ovary Syndrome. J Womens Health (Larchmt). 2022 06; 31(6):751-752.
    View in: PubMed
    Score: 0.046
  4. The natural history of polycystic ovary syndrome: commentary on a longitudinal study evaluating changes in phenotype with age. Fertil Steril. 2022 05; 117(5):1067-1068.
    View in: PubMed
    Score: 0.046
  5. Hyperlipidemia and risk for preclampsia. J Clin Lipidol. 2022 May-Jun; 16(3):253-260.
    View in: PubMed
    Score: 0.045
  6. Hormone therapy formulation, dose, route of delivery, and risk of hypertension: findings from the Women's Health Initiative Observational Study (WHI-OS). Menopause. 2021 07 26; 28(10):1108-1116.
    View in: PubMed
    Score: 0.043
  7. Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative. Menopause. 2021 05 03; 28(6):610-618.
    View in: PubMed
    Score: 0.043
  8. Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective. J Clin Lipidol. 2021 May-Jun; 15(3):423-430.
    View in: PubMed
    Score: 0.042
  9. Role of Lipid Management in Women's Health Preventive Care. Obstet Gynecol Clin North Am. 2021 Mar; 48(1):173-191.
    View in: PubMed
    Score: 0.042
  10. Thyroid autoantibodies: to treat or not to treat? Fertil Steril. 2020 12; 114(6):1185-1186.
    View in: PubMed
    Score: 0.041
  11. Metformin, rosiglitazone, or both for obese women with polycystic ovary syndrome? Fertil Steril. 2020 01; 113(1):87-88.
    View in: PubMed
    Score: 0.039
  12. Clinical utility of ovarian-stimulation intrauterine insemination. Fertil Steril. 2018 05; 109(5):795-796.
    View in: PubMed
    Score: 0.035
  13. JCL roundtable: Managing lipid disorders in young women. J Clin Lipidol. 2016 Sep-Oct; 10(5):1058-66.
    View in: PubMed
    Score: 0.031
  14. The risks of statin use in pregnancy: A systematic review. J Clin Lipidol. 2016 Sep-Oct; 10(5):1081-90.
    View in: PubMed
    Score: 0.031
  15. Improving reporting of research reports. Fertil Steril. 2016 05; 105(5):1155-1156.
    View in: PubMed
    Score: 0.030
  16. Dyslipidemia in pregnancy. Cardiol Clin. 2015 May; 33(2):209-15.
    View in: PubMed
    Score: 0.028
  17. Women's Health Considerations for Lipid Management. Cardiol Clin. 2015 May; 33(2):217-31.
    View in: PubMed
    Score: 0.028
  18. Insights from the Women's Health Initiative: individualizing risk assessment for hormone therapy decisions. Semin Reprod Med. 2014 Nov; 32(6):433-7.
    View in: PubMed
    Score: 0.027
  19. Clinical intervention to reduce central obesity and menopausal symptoms in women aged 35 to 55 years. Menopause. 2014 Sep; 21(9):975-81.
    View in: PubMed
    Score: 0.027
  20. Osteoporosis: therapeutic guidelines. Guidelines for practice management of osteoporosis. Clin Obstet Gynecol. 2013 Dec; 56(4):694-702.
    View in: PubMed
    Score: 0.026
  21. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials. Menopause. 2013 Mar; 20(3):254-60.
    View in: PubMed
    Score: 0.024
  22. Does age affect visualization of the levator ani in nulliparous women? Int Urogynecol J. 2013 Sep; 24(9):1507-13.
    View in: PubMed
    Score: 0.024
  23. Planning a clinical trial. J Clin Lipidol. 2012 Nov-Dec; 6(6):484-95.
    View in: PubMed
    Score: 0.024
  24. Randomized trial comparing office flexible to rigid cystoscopy in women. Int Urogynecol J. 2012 Nov; 23(11):1625-30.
    View in: PubMed
    Score: 0.023
  25. Atherosclerotic burden during the menopausal transition is a wakeup call. Menopause. 2012 Jan; 19(1):1-2.
    View in: PubMed
    Score: 0.022
  26. Dyslipidemia in PCOS. Steroids. 2012 Mar 10; 77(4):295-9.
    View in: PubMed
    Score: 0.022
  27. Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2012 Jan; 97(1):225-30.e2.
    View in: PubMed
    Score: 0.022
  28. Overlapping compared with end-to-end repair of third- and fourth-degree obstetric anal sphincter tears: a randomized controlled trial. Obstet Gynecol. 2011 Feb; 117(2 Pt 1):409.
    View in: PubMed
    Score: 0.021
  29. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011 Mar 01; 95(3):1073-9.e1-11.
    View in: PubMed
    Score: 0.021
  30. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol. 2011 Jan; 117(1):145-152.
    View in: PubMed
    Score: 0.021
  31. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010 May; 95(5):2038-49.
    View in: PubMed
    Score: 0.020
  32. Intrauterine tobacco exposure may alter auditory brainstem responses in newborns. Acta Obstet Gynecol Scand. 2010; 89(4):592-596.
    View in: PubMed
    Score: 0.020
  33. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts? Semin Reprod Med. 2009 Jul; 27(4):299-305.
    View in: PubMed
    Score: 0.019
  34. The need for evidence-based medicine to be integrated into clinical practice: role of the North American Menopause Society. Menopause. 2009 May-Jun; 16(3):438-41.
    View in: PubMed
    Score: 0.019
  35. Pioglitazone and metformin for increased small low-density lipoprotein in polycystic ovary syndrome: counterpoint. Am J Obstet Gynecol. 2008 Jan; 198(1):4-6.
    View in: PubMed
    Score: 0.017
  36. Endogenous androgens and cardiovascular risk. Menopause. 2007 Jul-Aug; 14(4):609-10.
    View in: PubMed
    Score: 0.016
  37. Options for hormone therapy in women who have had a hysterectomy. Menopause. 2007 May-Jun; 14(3 Pt 2):592-7; quiz 598-9.
    View in: PubMed
    Score: 0.016
  38. Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician. Clin Obstet Gynecol. 2007 Mar; 50(1):226-43.
    View in: PubMed
    Score: 0.016
  39. Coronary artery calcification and osteoporosis: is estrogen an important link? Menopause. 2005 Nov-Dec; 12(6):661-3.
    View in: PubMed
    Score: 0.015
  40. Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005 Jul; 90(7):4112-4.
    View in: PubMed
    Score: 0.014
  41. Intergenerational Occurrence of Premature Birth and Reproductive Health in Prematurely-Born Women in the Women's Health Initiative. Matern Child Health J. 2024 Oct; 28(10):1793-1811.
    View in: PubMed
    Score: 0.013
  42. The association between reproductive history and abdominal adipose tissue among postmenopausal women: results from the Women's Health Initiative. Hum Reprod. 2024 Aug 01; 39(8):1804-1815.
    View in: PubMed
    Score: 0.013
  43. The effect of improved metabolic syndrome parameters on live birth. Fertil Steril. 2024 Aug; 122(2):373-375.
    View in: PubMed
    Score: 0.013
  44. Association of maternal birth weight and maternal preterm birth with subsequent risk for adverse reproductive outcomes: The Women's Health Initiative. Early Hum Dev. 2023 09; 184:105839.
    View in: PubMed
    Score: 0.013
  45. Healthy Lifestyle Index and Risk of Cardiovascular Disease Among Postmenopausal Women With Normal Body Mass Index. J Am Heart Assoc. 2023 06 20; 12(12):e029111.
    View in: PubMed
    Score: 0.012
  46. Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab. 2003 Mar; 88(3):1048-54.
    View in: PubMed
    Score: 0.012
  47. Association of Preterm Birth With Prevalent and Incident Hypertension, Early-Onset Hypertension, and Cardiovascular Disease in the Women's Health Initiative. Am J Cardiol. 2023 04 01; 192:132-138.
    View in: PubMed
    Score: 0.012
  48. Longitudinal patterns of abdominal visceral and subcutaneous adipose tissue, total body composition, and anthropometric measures in postmenopausal women: Results from the Women's Health Initiative. Int J Obes (Lond). 2023 Apr; 47(4):288-296.
    View in: PubMed
    Score: 0.012
  49. The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials. Menopause. 2023 01 01; 30(1):28-36.
    View in: PubMed
    Score: 0.012
  50. The severity of individual menopausal symptoms, cardiovascular disease, and all-cause mortality in the Women's Health Initiative Observational Cohort. Menopause. 2022 Dec 01; 29(12):1365-1374.
    View in: PubMed
    Score: 0.012
  51. Blood Pressure Variability and Heart Failure Hospitalization: Results From the Women's Health Initiative. Am J Prev Med. 2022 09; 63(3):410-418.
    View in: PubMed
    Score: 0.011
  52. Long-term health consequences of PCOS. Hum Reprod Update. 2002 May-Jun; 8(3):231-41.
    View in: PubMed
    Score: 0.011
  53. Association of infertility with atherosclerotic cardiovascular disease among postmenopausal participants in the Women's Health Initiative. Fertil Steril. 2022 05; 117(5):1038-1046.
    View in: PubMed
    Score: 0.011
  54. Analgesic Use and Circulating Estrogens, Androgens, and Their Metabolites in the Women's Health Initiative Observational Study. Cancer Prev Res (Phila). 2022 03 01; 15(3):173-183.
    View in: PubMed
    Score: 0.011
  55. A personalized medicine approach to ovulation induction/ovarian stimulation: development of a predictive model and online calculator from level-I evidence. Fertil Steril. 2022 02; 117(2):408-418.
    View in: PubMed
    Score: 0.011
  56. Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol. Cancer Med. 2022 02; 11(4):1145-1159.
    View in: PubMed
    Score: 0.011
  57. Effects of preconception lifestyle intervention in infertile women with obesity: The FIT-PLESE randomized controlled trial. PLoS Med. 2022 01; 19(1):e1003883.
    View in: PubMed
    Score: 0.011
  58. Polycystic ovary syndrome: a risk for coronary artery disease? Am J Obstet Gynecol. 2002 Jan; 186(1):35-43.
    View in: PubMed
    Score: 0.011
  59. Body Fat Distribution, Cardiometabolic Traits, and Risk of Major Lower-Extremity Arterial Disease in Postmenopausal Women. Diabetes Care. 2022 01 01; 45(1):222-231.
    View in: PubMed
    Score: 0.011
  60. Adverse Pregnancy Outcomes and Incident Heart Failure in the Women's Health Initiative. JAMA Netw Open. 2021 12 01; 4(12):e2138071.
    View in: PubMed
    Score: 0.011
  61. Recreational Physical Activity, Sitting, and Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev. 2022 01; 31(1):97-107.
    View in: PubMed
    Score: 0.011
  62. Obesity, Height, and Serum Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev. 2021 11; 30(11):2018-2029.
    View in: PubMed
    Score: 0.011
  63. Effect of an Active vs Expectant Management Strategy on Successful Resolution of Pregnancy Among Patients With a Persisting Pregnancy of Unknown Location: The ACT or NOT Randomized Clinical Trial. JAMA. 2021 08 03; 326(5):390-400.
    View in: PubMed
    Score: 0.011
  64. Androgens and syndrome X. Menopause. 2001 Jul-Aug; 8(4):229.
    View in: PubMed
    Score: 0.011
  65. Metabolic syndrome in obesity: treatment success and adverse pregnancy outcomes with ovulation induction in polycystic ovary syndrome. Am J Obstet Gynecol. 2021 09; 225(3):280.e1-280.e11.
    View in: PubMed
    Score: 0.011
  66. Dietary cholesterol and egg intake in relation to incident cardiovascular disease and all-cause and cause-specific mortality in postmenopausal women. Am J Clin Nutr. 2021 04 06; 113(4):948-959.
    View in: PubMed
    Score: 0.011
  67. Estrogens, progestins, selective estrogen receptor modulators, and the arterial tree. Am J Obstet Gynecol. 2001 Apr; 184(5):1031-9.
    View in: PubMed
    Score: 0.011
  68. Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative. Cancer. 2021 05 15; 127(10):1658-1667.
    View in: PubMed
    Score: 0.010
  69. The severity of vasomotor symptoms and number of menopausal symptoms in postmenopausal women and select clinical health outcomes in the Women's Health Initiative Calcium and Vitamin D randomized clinical trial. Menopause. 2020 11; 27(11):1265-1273.
    View in: PubMed
    Score: 0.010
  70. The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative. Menopause. 2020 10; 27(10):1117-1125.
    View in: PubMed
    Score: 0.010
  71. Walking Volume and Speed Are Inversely Associated With Incidence of Treated Hypertension in Postmenopausal Women. Hypertension. 2020 11; 76(5):1435-1443.
    View in: PubMed
    Score: 0.010
  72. Lipoprotein(a) levels and risk of abdominal aortic aneurysm in the Women's Health Initiative. J Vasc Surg. 2021 04; 73(4):1245-1252.e3.
    View in: PubMed
    Score: 0.010
  73. Feasibility and Utility of a Cardiovascular Risk Screening Tool in Women Undergoing Routine Gynecology Evaluation. J Womens Health (Larchmt). 2020 09; 29(9):1150-1159.
    View in: PubMed
    Score: 0.010
  74. Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial. Hum Reprod. 2020 06 01; 35(6):1296-1305.
    View in: PubMed
    Score: 0.010
  75. The effect of antioxidants on male factor infertility: the Males, Antioxidants, and Infertility (MOXI) randomized clinical trial. Fertil Steril. 2020 03; 113(3):552-560.e3.
    View in: PubMed
    Score: 0.010
  76. Associations between Serum Levels of Cholesterol and Survival to Age 90 in Postmenopausal Women. J Am Geriatr Soc. 2020 02; 68(2):288-296.
    View in: PubMed
    Score: 0.010
  77. It's Absolutely Relative: The Effect of Age on the BMI-Mortality Relationship in Postmenopausal Women. Obesity (Silver Spring). 2020 01; 28(1):171-177.
    View in: PubMed
    Score: 0.010
  78. The Effects of Reverse Causality and Selective Attrition on the Relationship Between Body Mass Index and Mortality in Postmenopausal Women. Am J Epidemiol. 2019 10 01; 188(10):1838-1848.
    View in: PubMed
    Score: 0.010
  79. Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. Eur Heart J. 2019 09 07; 40(34):2849-2855.
    View in: PubMed
    Score: 0.010
  80. Fertility Related Quality of Life, Gonadal Function and Erectile Dysfunction in Male Partners of Couples with Unexplained Infertility. J Urol. 2019 08; 202(2):379-384.
    View in: PubMed
    Score: 0.009
  81. Association between testosterone, semen parameters, and live birth in men with unexplained infertility in an intrauterine insemination population. Fertil Steril. 2019 06; 111(6):1129-1134.
    View in: PubMed
    Score: 0.009
  82. Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study. Cancer Causes Control. 2019 Apr; 30(4):355-363.
    View in: PubMed
    Score: 0.009
  83. Luteal-phase progesterone supplementation in non-IVF treatment: a survey of physicians providing infertility treatment. Hum Fertil (Camb). 2020 Dec; 23(4):239-245.
    View in: PubMed
    Score: 0.009
  84. Risk factors: assessment and preventive measures. Clin Obstet Gynecol. 1998 Dec; 41(4):966-75.
    View in: PubMed
    Score: 0.009
  85. The efficiency of single institutional review board review in National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network-initiated clinical trials. Clin Trials. 2019 02; 16(1):3-10.
    View in: PubMed
    Score: 0.009
  86. Lipids and Women's Health: Recent Updates and Implications for Practice. J Womens Health (Larchmt). 2019 06; 28(6):752-760.
    View in: PubMed
    Score: 0.009
  87. Midluteal Progesterone: A Marker of Treatment Outcomes in Couples With Unexplained Infertility. J Clin Endocrinol Metab. 2018 07 01; 103(7):2743-2751.
    View in: PubMed
    Score: 0.009
  88. Metabolic aspects of polycystic ovary syndrome. Semin Reprod Endocrinol. 1997 May; 15(2):105-10.
    View in: PubMed
    Score: 0.008
  89. Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility. Fertil Steril. 2017 Mar; 107(3):756-762.e3.
    View in: PubMed
    Score: 0.008
  90. Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study. J Clin Lipidol. 2016 Jul-Aug; 10(4):833-841.
    View in: PubMed
    Score: 0.007
  91. Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination. Fertil Steril. 2016 Jun; 105(6):1575-1583.e2.
    View in: PubMed
    Score: 0.007
  92. Estrogen: effects on the cardiovascular tree. Obstet Gynecol. 1996 Feb; 87(2 Suppl):27S-35S.
    View in: PubMed
    Score: 0.007
  93. Hormone replacement: effects on atherogenesis. Semin Reprod Endocrinol. 1996 Feb; 14(1):63-9.
    View in: PubMed
    Score: 0.007
  94. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. J Clin Lipidol. 2015 Nov-Dec; 9(6 Suppl):S1-122.e1.
    View in: PubMed
    Score: 0.007
  95. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report. J Clin Lipidol. 2015 Mar-Apr; 9(2):129-69.
    View in: PubMed
    Score: 0.007
  96. Obesity, lipids, cardiovascular risk, and androgen excess. Am J Med. 1995 Jan 16; 98(1A):27S-32S.
    View in: PubMed
    Score: 0.007
  97. The gynecologist and the prevention of cardiovascular disease. Am J Obstet Gynecol. 1995 Jan; 172(1 Pt 1):1-13.
    View in: PubMed
    Score: 0.007
  98. In high responding patients undergoing an initial IVF cycle, elevated estradiol on the day of hCG has no effect on live birth rate. Reprod Biol Endocrinol. 2014 Nov 28; 12:119.
    View in: PubMed
    Score: 0.007
  99. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary. J Clin Lipidol. 2014 Sep-Oct; 8(5):473-88.
    View in: PubMed
    Score: 0.007
  100. Role of endogenous estrogen in the hirsutism paradigm. J Reprod Med. 1994 Apr; 39(4):273-6.
    View in: PubMed
    Score: 0.007
  101. The gynecologist and cardiovascular disease: a window of opportunity for prevention. J Soc Gynecol Investig. 1994 Apr-Jun; 1(2):107-17.
    View in: PubMed
    Score: 0.007
  102. Matriarchal model for cardiovascular prevention. Obstet Gynecol Surv. 1994 Feb; 49(2):147-52.
    View in: PubMed
    Score: 0.006
  103. Whole endometrial fragments form characteristics of in vivo endometriosis in a mesothelial cell co-culture system: an in vitro model for the study of the histogenesis of endometriosis. J Soc Gynecol Investig. 1994 Jan-Mar; 1(1):65-8.
    View in: PubMed
    Score: 0.006
  104. Lipoprotein abnormalities in hirsute women. II. Compensatory responses of insulin resistance and dehydroepiandrosterone sulfate with obesity. Am J Obstet Gynecol. 1992 Dec; 167(6):1813-8.
    View in: PubMed
    Score: 0.006
  105. Detection of antiendometrial antibodies in patients with endometriosis: methodological issues. Fertil Steril. 1992 Sep; 58(3):518-21.
    View in: PubMed
    Score: 0.006
  106. Evaluation of endometrial tissue specific complement activation in women with endometriosis. Fertil Steril. 1992 Apr; 57(4):787-95.
    View in: PubMed
    Score: 0.006
  107. Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance. Am J Obstet Gynecol. 1992 Apr; 166(4):1191-6; discussion 1196-7.
    View in: PubMed
    Score: 0.006
  108. Hyperandrogenism in the adolescent. Obstet Gynecol Clin North Am. 1992 Mar; 19(1):71-89.
    View in: PubMed
    Score: 0.006
  109. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012 Jan; 97(1):28-38.e25.
    View in: PubMed
    Score: 0.006
  110. Lipid metabolism and hyperandrogenism. Clin Obstet Gynecol. 1991 Dec; 34(4):864-71.
    View in: PubMed
    Score: 0.006
  111. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012 Mar-Apr; 18(2):112-26.
    View in: PubMed
    Score: 0.006
  112. F(ab')2 segment is the active component of immunoglobulin G autoantibody generation in patients with endometriosis. Fertil Steril. 1991 Nov; 56(5):900-3.
    View in: PubMed
    Score: 0.006
  113. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone. Contraception. 1991 Aug; 44(2):113-24.
    View in: PubMed
    Score: 0.005
  114. Autoantibodies associated with endometriosis: can their detection predict presence of the disease? Obstet Gynecol. 1991 Jun; 77(6):927-31.
    View in: PubMed
    Score: 0.005
  115. Endometrial antibodies versus CA-125 for the detection of endometriosis. Fertil Steril. 1991 Jan; 55(1):90-4.
    View in: PubMed
    Score: 0.005
  116. Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study. Clin Endocrinol (Oxf). 2011 Jan; 74(1):89-96.
    View in: PubMed
    Score: 0.005
  117. Evidence of heterogeneous mechanisms in lipoprotein lipid alterations in hyperandrogenic women. Am J Obstet Gynecol. 1990 Dec; 163(6 Pt 1):1998-2005.
    View in: PubMed
    Score: 0.005
  118. Maternal diabetes and renal agenesis/dysgenesis. Birth Defects Res A Clin Mol Teratol. 2010 Sep; 88(9):722-7.
    View in: PubMed
    Score: 0.005
  119. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril. 1990 Aug; 54(2):255-9.
    View in: PubMed
    Score: 0.005
  120. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010 Jul-Aug; 16(4):347-63.
    View in: PubMed
    Score: 0.005
  121. Lipoprotein lipids in women with androgen excess: independent associations with increased insulin and androgen. Clin Chem. 1990 Feb; 36(2):283-9.
    View in: PubMed
    Score: 0.005
  122. The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome. Am J Obstet Gynecol. 1988 Aug; 159(2):423-7.
    View in: PubMed
    Score: 0.004
  123. Declining adrenal androgens: an association with bone loss in aging women. Proc Soc Exp Biol Med. 1987 Dec; 186(3):355-60.
    View in: PubMed
    Score: 0.004
  124. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1985 Nov; 61(5):946-51.
    View in: PubMed
    Score: 0.004
  125. Hysterectomy prevalence and cardiovascular disease risk factors in American Indian women. Maturitas. 2005 Nov-Dec; 52(3-4):328-36.
    View in: PubMed
    Score: 0.004
  126. Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study. J Womens Health (Larchmt). 2004 Mar; 13(2):155-63.
    View in: PubMed
    Score: 0.003
  127. Adrenal function in hirsutism. II. Effect of an oral contraceptive. J Clin Endocrinol Metab. 1982 Apr; 54(4):676-81.
    View in: PubMed
    Score: 0.003
  128. The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in american Indian postmenopausal women : the strong heart study. Diabetes Care. 2002 Mar; 25(3):500-4.
    View in: PubMed
    Score: 0.003
  129. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab. 2000 Jan; 85(1):214-8.
    View in: PubMed
    Score: 0.002
  130. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA. 1998 May 13; 279(18):1445-51.
    View in: PubMed
    Score: 0.002
  131. Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group. Climacteric. 1998 Mar; 1(1):26-32.
    View in: PubMed
    Score: 0.002
  132. Antibodies to carbonic anhydrase in endometriosis: prevalence, specificity, and relationship to clinical and laboratory parameters. Fertil Steril. 1996 Oct; 66(4):547-56.
    View in: PubMed
    Score: 0.002
  133. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group. Obstet Gynecol. 1994 Dec; 84(6):987-95.
    View in: PubMed
    Score: 0.002
  134. Antigenic similarities between respiratory and reproductive tract mucins: heterogeneity of mucin expression by human endocervix and endometrium. Fertil Steril. 1993 Dec; 60(6):1011-9.
    View in: PubMed
    Score: 0.002
  135. Effect of tumor necrosis factor-alpha on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: an in vitro system. Fertil Steril. 1993 Jun; 59(6):1196-201.
    View in: PubMed
    Score: 0.002
  136. Vulvar acanthosis nigricans: a marker for insulin resistance in hirsute women. Fertil Steril. 1993 Mar; 59(3):583-6.
    View in: PubMed
    Score: 0.002
  137. Effects of peritoneal macrophages from patients with endometriosis on the proliferation of endometrial carcinoma cell line ECC-1. Am J Obstet Gynecol. 1991 Dec; 165(6 Pt 1):1842-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.